ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: FR-PO406

Comparative Outcomes and Risk Analysis of Stroke Incidence in Adult Patients on Dialysis

Session Information

Category: Dialysis

  • 801 Dialysis: Hemodialysis and Frequent Dialysis

Authors

  • Subhash, Sanat, Department of Nephrology, Akron Nephrology Associates/Cleveland Clinic Akron General Medical Center, Akron, Ohio, United States
  • Rabbani, Haziq H., Department of Nephrology, Akron Nephrology Associates/Cleveland Clinic Akron General Medical Center, Akron, Ohio, United States
  • Raina, Rupesh, Department of Nephrology, Akron Nephrology Associates/Cleveland Clinic Akron General Medical Center, Akron, Ohio, United States
Background

Kidney failure requiring dialysis and its associated costs create substantial burdens on healthcare systems. This study leverages electronic healthcare data to analyze comorbid stroke incidence in ICU dialysis patients over time, characterize stroke epidemiology, and compare outcomes between ICU dialysis stroke patients and non-stroke ICU dialysis patients.

Methods

Using ICD-10 and CPT code queries, adult (18-90 years) ICU patients on dialysis from March 2004 to March 2024 were categorized into three cohorts: (1) non-stroke patients (n=120,414), (2) stroke patients (n=5,750), and (3) ICU dialysis patients (n=128,564). These cohorts were filtered by exclusion factors (kidney transplant status and history of stroke). Cohorts 1 and 2 were propensity-matched for severity of illness (use of vasopressors or ventilation), demographics, diagnoses, medications, and lab values (n=5,698) and used for the comparative outcomes analysis. Cohort 2 pre-matching was also used for the risks analysis, and cohort 3 was used for the incidence and prevalence analysis.

Results

The identified comorbidities for stroke were diabetes (18.42% of patients), heart failure (17.01%), hypertension (13.62%), atrial fibrillation (12.07%), coronary artery disease (11.27%), peripheral artery disease (3.27%), sleep apnea (1.16%), arthritis (0.29%), and lupus (0.08%). ICU dialysis stroke patients had significant increases (p<0.05) in rates of mortality (+4.30%) and ventilation/intubation (+1.98%), while non-stroke patients had significant increases (p<0.05) in ED visitation (+7.95%) and rehospitalization (+4.42%). ICU readmission rates showed no significant difference (p=0.07). Women and older adults reported higher stroke risk, but there were no significant disparities across racial and ethnic groups.

Conclusion

Stroke has a significant, adverse impact on ICU dialysis patients. Preventative strategies targeting stroke comorbidities are crucial to enhancing patient well-being and mitigating stroke burden.